Recerca

Dianes farmacològiques en inflamació i malalties metabòliques

Buscador de publicacions

Publicacions

  • Aguilar-Recarte D, Palomer FX, Wahli W and Vazquez M.

    The PPARß/d-AMPK Connection in the Treatment of Insulin Resistance.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 22(16): 8555. Nº de cites: 20

    [doi:10.3390/ijms22168555]

  • Palomer FX, Aguilar-Recarte D, García R, Nistal JF and Vazquez M.

    Sirtuins: To Be or Not To Be in Diabetic Cardiomyopathy.

    TRENDS IN MOLECULAR MEDICINE . 27(6): 554-571. Nº de cites: 27

    [doi:10.1016/j.molmed.2021.03.004]

  • Codony S, Calvó-Tusell C, Valverde E, Osuna S, Morisseau C, Loza MI, Brea J, Pérez C, Rodríguez-Franco MI, Pizarro J, Corpas R, Griñán-Ferré C, Pallàs M, Sanfeliu C, Vazquez M, Hammock BD, Feixas F and Vázquez S.

    From the Design to the In Vivo Evaluation of Benzohomoadamantane-Derived Soluble Epoxide Hydrolase Inhibitors for the Treatment of Acute Pancreatitis.

    JOURNAL OF MEDICINAL CHEMISTRY . 64(9): 5429-5446. Nº de cites: 17

    [doi:10.1021/acs.jmedchem.0c01601]

  • Aguilar-Recarte D, Palomer FX and Vazquez M.

    Uncovering the role of apolipoprotein C-III in insulin resistance

    Clinica e Investigacion en Arteriosclerosis . 33(2): 108-115. Nº de cites: 4

    [doi:10.1016/j.arteri.2020.09.003]

  • Sala E, Vived C, Luna J, Saavedra-Ávila NA, Sengupta U, Castaño AR, Villar-Pazos S, Haba L, Verdaguer J, Ropero AB, Stratmann T, Pizarro J, Vazquez M, Nadal A, Lahti JM and Mora C.

    CDK11 Promotes Cytokine-Induced Apoptosis in Pancreatic Beta Cells Independently of Glucose Concentration and Is Regulated by Inflammation in the NOD Mouse Model.

    FRONTIERS IN IMMUNOLOGY . 12: 634797-634797. Nº de cites: 2

    [doi:10.3389/fimmu.2021.634797]

  • Zarei M, Aguilar-Recarte D, Palomer FX and Vazquez M.

    Revealing the role of peroxisome proliferator-activated receptor beta/delta in nonalcoholic fatty liver disease

    METABOLISM-CLINICAL AND EXPERIMENTAL . 114: 154342-154342. Nº de cites: 31

    [doi:10.1016/j.metabol.2020.154342]

  • Codony S, Pujol E, Pizarro J, Feixas F, Valverde E, Loza MI, Brea JM, Saez E, Oyarzabal J, Pineda-Lucena A, Pérez-Dueñas B, Pérez C, Rodríguez-Franco MI, Leiva R, Osuna S, Morisseau C, Hammock BD, Vazquez M and Vázquez S.

    2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis

    JOURNAL OF MEDICINAL CHEMISTRY . 63(17): 9237-9257. Nº de cites: 18

    [doi:10.1021/acs.jmedchem.0c00310]

  • Barroso E, Rodríguez-Rodríguez R, Zarei M, Pizarro-Degado J, Planavila A, Palomer FX, Villarroya-Gombau F and Vazquez M.

    SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1 alpha-LIPIN 1 pathway and increasing CD36 through Nrf2

    CELL COMMUNICATION AND SIGNALING . 18(1): 147-147. Nº de cites: 27

    [doi:10.1186/s12964-020-00640-8]

  • Zarei M, Pizarro J, Barroso E, Palomer FX and Vazquez M.

    Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis

    TRENDS IN PHARMACOLOGICAL SCIENCES . 41(3): 199-208. Nº de cites: 68

    [doi:10.1016/j.tips.2019.12.005]

  • Palomer FX, Román-Azcona MS, Pizarro J, Planavila A, Villarroya-Gombau F, Valenzuela-Alcaraz BI, Crispi F, Sepúlveda-Martínez Á, Miguel-Escalada I, Ferrer J, Nistal JF, García R, Davidson MM, Barroso E and Vazquez M.

    SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.

    signal transduction and targeted therapy . 5(1): 14-14. Nº de cites: 111

    [doi:10.1038/s41392-020-0114-1]